← Back
$CADL All transactions

Candel Therapeutics, Inc.

A

$ Value

$520K

Shares

111,349

Price

$5

Filed

Jun 26

Insider

Name

Martell Christopher

Title

CIK

0001873465

Roles

Director

Transaction Details

Transaction Date

2025-06-25

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

111,349

Footnotes

Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. | Shares held by Spouse. | Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. | Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Filing Info

Accession No.

0000950170-25-090196

Form Type

4

Issuer CIK

0001841387

Martell Christopher's History

Date Ticker Type Value
2025-06-25 CADL A $520K
2025-06-17 CADL A $0

Other Insiders at CADL (90d)

Insider Bought Sold Last
Manning Paul B $3.0M 2026-03-31
PAPA JOSEPH C 2026-03-31
Nichols William Garrett
Chief Medical Officer
2026-01-26
Tak Paul Peter
Chief Executive Officer
2026-01-26
Barone Francesca
Chief Scientific Officer
2026-01-26
Tyagarajan Seshu
Chief Technology Officer
2026-01-26
Loggia Nicoletta 2026-03-31
Schoch Charles
Chief Financial Officer
2026-01-26